IL28B

Interleukin-28B (IL28B), also known as IFN-λ3, is a gene that has drawn significant attention in the field of pharmacogenetics due to its role in the treatment of Hepatitis C Virus (HCV) infection. Understanding the genetic variations of IL28B can aid in predicting an individual’s response to antiviral therapy, thereby offering a more personalized approach to Hepatitis C treatment.